SCHEMBL2881164

SCHEMBL2881164

N=C(NO)c1nn(Cc2ccccc2F)c2ncnc(N)c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.54
PIK3CD O00329 10/20 0.50
LRRK2 Q5S007 1/20 0.44
PIK3CG P48736 7/20 0.42
PIK3C2B O00750 2/20 0.39
PIK3CA P42336 3/20 0.38
PIK3CB P42338 3/20 0.38
PRKDC P78527 3/20 0.38
ABL1 P00519 2/20 0.38
EGFR P00533 2/20 0.38
HCK P08631 2/20 0.38
SRC P12931 2/20 0.38
KDR P35968 2/20 0.38
MTOR P42345 2/20 0.38
EPHB4 P54760 2/20 0.38
PI4KB Q9UBF8 2/20 0.38
JAK2 O60674 1/20 0.38
JAK1 P23458 1/20 0.38
JAK3 P52333 1/20 0.38
MAP4K4 O95819 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2881160 0.81 BTK (0.55) BTKPIK3CDLRRK2PIK3CGPIK3C2B
SCHEMBL2881157 0.81 BTK (0.55) BTKPIK3CDLRRK2PIK3CGPIK3C2B
SCHEMBL8226946 0.81 BTK (0.55) BTKPIK3CDLRRK2PIK3CGPIK3C2B
SCHEMBL2883929 0.76 ADORA3 (0.46) PDE5AADORA3KCNH2
SCHEMBL2880679 0.75 BTK (0.58) BTKPIK3CDLRRK2PIK3CGPIK3C2B
SCHEMBL15169740 0.72 PDE5A (0.46) BTKPIK3CDABL1SRCPDE5A
SCHEMBL15111666 0.72 PDE5A (0.44) BTKPIK3CDABL1SRCPDE5A
SCHEMBL6868182 0.72 BTK (0.62) BTKPIK3CDPIK3CGPIK3C2BPIK3CA
SCHEMBL28407417 0.70 BTK (1.00) BTKPIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL6060744 0.70 BTK (0.57) BTKPIK3CDLRRK2PIK3CGPIK3C2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004235-A1 Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses BAYER HEALTHCARE AG (DE) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004235-A1 Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses AADAC, CYP11B2, PC BTK 3577/4885PIK3CD 2681/4885LRRK2 4503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.